Kenvue Inc. may have to start sharing time with Bausch + Lomb Corp. in investors’ discussions about the outlook for success at US consumer health firms separated from former parent firms as they and their competitors begin reporting the results for their latest quarters.
That’s because five months into its third year after spinning out from Bausch Health Companies Inc. in an initial public offering of shares, B+L has been reported as the target...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?